MIMEDX GROUP, INC.
MDXGNasdaqHealthcare · Surgical & Medical Instruments & Apparatus · SEC filings ↗ · Compare ⊕
View price & chart on Yahoo Finance ↗Financials
SEC XBRL · annual| FY25 | FY24 | FY23 | FY22 | FY21 | FY20 | |
|---|---|---|---|---|---|---|
| Revenue | $418.6M | $348.9M | $321.5M | $267.8M | $242.0M | $248.2M |
| Operating income | $63.9M | $58.9M | $37.1M | −$14.7M | −$7.1M | −$45.4M |
| Net income | $48.6M | $42.4M | $58.2M | −$30.2M | −$10.3M | −$49.3M |
| Total assets | $342.7M | $263.9M | $239.0M | $171.4M | $187.9M | $202.0M |
| Total liabilities | $86.1M | $70.8M | $96.3M | $96.9M | $95.4M | $110.6M |
| Equity | $256.5M | $193.1M | $142.7M | −$18.0M | $82,000 | −$150,000 |
| EPS (diluted) | $0.32 | $0.28 | $0.37 | $-0.33 | $-0.15 | $-0.77 |
| Shares out. | 147.4M | 147.0M | 114.1M | 112.4M | 111.3M | 110.3M |
Reported figures from the company's SEC filings (XBRL). Blank where a line item isn't cleanly tagged — never estimated.
Key ratios
from filings · FY2025- Operating margin
- 15.3%
- Net margin
- 11.6%
- Return on equity
- 18.9%
- Return on assets
- 14.2%
- Return on capital (ROCE)
- 22.9%
- Liabilities / assets
- 25.1%
- Debt / equity
- 0.34×
- Book value / share
- $1.74
- Revenue growth (YoY)
- 20.0%
- Net income growth (YoY)
- 14.5%
Computed from the company's own SEC figures — no market price, so these are facts, not a valuation. Book value per share is reported equity ÷ shares; it is not the stock price.
Financial health
forensic scores · FY2025- Altman Z″ (distress)
- 8.06safe
- Accruals / assets
- −7.4%clean
- Piotroski F-Score
- 5/9mixed
Altman Z″is a textbook bankruptcy-distress score from book values only (>2.6 safe · 1.1–2.6 grey · <1.1 distress). Accruals = (net income − operating cash flow) ÷ assets; persistently high accruals are an earnings-quality red flag. Beneish M-Scoreis an eight-ratio screen comparing this year with last (M > −1.78 = elevated manipulation-risk screen, not proof). Piotroski F-Scorecounts how many of nine fundamental-health checks pass (shown as passed / applicable; we use operating margin and total liabilities as documented proxies where the exact input isn't XBRL-tagged). Computed from SEC filings — descriptive factors, not advice or a forecast.
Quality score
EDS ScoreOur own multi-factor score from free SEC data — profitability, growth, financial strength, earnings quality, and event/ownership catalysts. No market price and no licensed model: each axis is the share of source-backed checks it passes. Descriptive factors, not advice or a forecast.
Signs
● 1 severe● 7 good- Filed a late-filing notice (Form NT) — missed an SEC deadline
- Operating margin is positive
- Strong return on equity (>15%)
- Revenue is growing year-over-year
- Conservative leverage (liabilities < 50% of assets)
- Positive operating cash flow
- Clean earnings (low accruals)
- Altman Z″ in the safe zone
Derived from the company's own SEC figures (fundamentals, forensic scores, filing discipline) — descriptive factors, not advice or a forecast.
Risk flags
late SEC filings- NT 10-Qmissed a reporting deadline ↗May 11, 2020
- NT 10-Kmissed a reporting deadline ↗Mar 18, 2020
- NT 10-Qmissed a reporting deadline ↗Nov 12, 2019
- NT 10-Qmissed a reporting deadline ↗Aug 9, 2019
- NT 10-Qmissed a reporting deadline ↗May 10, 2019
- NT 10-Kmissed a reporting deadline ↗Mar 1, 2019
A Form NT means the company notified the SEC it would file a periodic report late — often an accounting, audit or liquidity warning sign. Also search SEC enforcement actions for this company.
5%+ owners
SEC Schedule 13D / 13G · last 3 yrs- Trigran Investments, Inc.Passive (13G)Feb 13, 2026
Holders who disclosed a 5%+ stake. 13D signals intent to influence or control; 13G is a passive holding. Latest filing per holder — open it for the exact stake.
Insider transactions
SEC Form 4 · most recent| Insider | Date | Type | Shares | Price |
|---|---|---|---|---|
| Hulse William Frank IvOfficer — General Counsel and CAO | Mar 13, 2026 | Tax withholding | 20,245 | $4.38 |
| Maersk-Moller KimberlyOfficer — Chief Commercial Officer | Mar 13, 2026 | Tax withholding | 6,762 | $4.38 |
| Maersk-Moller KimberlyOfficer — Chief Commercial Officer | Mar 10, 2026 | Option exercise | 42,845 | $4.50 |
| Hulse William Frank IvOfficer — General Counsel and CAO | Mar 10, 2026 | Option exercise | 136,364 | $4.50 |
| Doug RiceOfficer — Chief Financial Officer | Mar 10, 2026 | Option exercise | 243,000 | $4.50 |
| Capper Joseph HOfficer — Chief Executive Officer | Mar 4, 2026 | Grant | 371,094 | $0.00 |
| Doug RiceOfficer — Chief Financial Officer | Mar 4, 2026 | Grant | 74,163 | $0.00 |
| Hulse William Frank IvOfficer — General Counsel and CAO | Mar 4, 2026 | Grant | 74,987 | $0.00 |
| Whitlow Ricci SOfficer — Chief Operating Officer | Mar 4, 2026 | Grant | 74,163 | $0.00 |
| Maersk-Moller KimberlyOfficer — Chief Commercial Officer | Mar 4, 2026 | Grant | 74,163 | $0.00 |
| Whitlow Ricci SOfficer — Chief Operating Officer | Feb 13, 2026 | Tax withholding | 61,961 | $5.12 |
| Maersk-Moller KimberlyOfficer — Chief Commercial Officer | Nov 6, 2025 | Sell | 58,300 | $7.42 |
Headline trade per Form 4 (officers, directors, 10%+ owners). Buy/sell read from the filing's structured data — blank where a field isn't cleanly tagged.
Short interest
FINRA · bi-monthly| Settlement | Shares short | Days to cover | Δ vs prior |
|---|---|---|---|
| May 15, 2026 | 7.3M | 4.1 | -13.0% |
| Apr 30, 2026 | 8.4M | 3.8 | +12.7% |
| Apr 15, 2026 | 7.4M | 6.2 | -3.0% |
| Mar 31, 2026 | 7.7M | 6.3 | +24.1% |
| Mar 13, 2026 | 6.2M | 7.5 | -7.9% |
Shares sold short as reported to FINRA. Days-to-cover = short shares ÷ average daily volume — higher means more potential squeeze pressure.
Material events
SEC Form 8-K · most recent- Results of operations · Regulation FD disclosureApr 29, 2026
- Director / officer change · Regulation FD disclosureApr 16, 2026
- Results of operations · Regulation FD disclosureFeb 25, 2026
- Regulation FD disclosureJan 12, 2026
- Results of operations · Regulation FD disclosureOct 29, 2025
- Regulation FD disclosureSep 3, 2025
- Results of operations · Regulation FD disclosureJul 30, 2025
- Shareholder voteJun 20, 2025
Events the company reported on Form 8-K, labelled by the SEC item code it filed under — its own classification, not our interpretation.
Recent SEC filings
All filings ↗Event-driven situations (1)
Spot an error in this record? Report it. Every correction is verified against the source filing before we change anything.